Related Experiment Video

Updated: Jun 27, 2025

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
10:06

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells

Published on: April 26, 2017

9.0K

Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer

De-Yi Geng1,2, Qing-Shan Chen1,2, Wan-Xian Chen1,2

  • 1Department of Plastic and Burns Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515000, Guangdong Province, China.

World Journal of Clinical Oncology
|May 1, 2024
PubMed

Insights

Alternative splicing significantly impacts metastatic liver cancer development and progression. Understanding these splicing alterations, including splicing factor changes and hypoxia, is crucial for improving cancer management and identifying new therapeutic targets.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Metastasis, particularly to the liver, is a primary cause of cancer mortality.
  • Alternative splicing generates RNA and protein diversity, influencing cancer development and drug resistance.
  • Dysfunctional splicing factors and aberrant splicing variants are linked to cancer occurrence, progression, and aggressiveness.

Purpose of the Study:

  • To provide a comprehensive review of normal splicing processes and their alterations in metastatic liver cancer.
  • To elucidate the role of alternative splicing in the mechanisms driving metastatic liver cancer.
  • To examine the impact of splicing factor changes, abnormal splicing, and hypoxia on liver metastasis.

Main Methods:

  • Literature review focusing on alternative splicing in metastatic liver cancer.
  • Analysis of the role of splicing factors and splicing variants in cancer progression.
  • Investigation of the contribution of hypoxia to splicing alterations in liver metastasis.

Main Results:

  • Alternative splicing is a key driver in the development and progression of metastatic liver cancer.
  • Splicing factor dysfunction and abnormal splicing variants are associated with increased cancer aggressiveness and drug resistance.
  • Hypoxia plays a role in promoting splicing alterations during liver metastasis.

Conclusions:

  • Alternative splicing represents a critical mechanism in metastatic liver cancer.
  • Targeting splicing alterations offers potential for novel therapeutic strategies.
  • Further research into splicing factor dynamics and hypoxia's role is warranted for improved cancer treatment.
Keywords:
Alternative splicingCarcinomaHepatocellularLiver neoplasmsMetastasicPrognosis

More Related Videos

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition11:48

Detection of Alternative Splicing During Epithelial-Mesenchymal Transition

Published on: October 9, 2014

12.9K
Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models09:58

Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models

Published on: December 9, 2016

13.7K

Related Concept Videos

RNA Splicing01:32

RNA Splicing

Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.3K
Alternative RNA Splicing02:18

Alternative RNA Splicing

Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.6K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Chromatin Structure Regulates pre-mRNA Processing02:41

Chromatin Structure Regulates pre-mRNA Processing

In eukaryotic cells, nascent mRNA transcripts need to undergo many post-transcriptional modifications to reach the cell cytoplasm and translate into functional proteins. For a long time, transcription and pre-mRNA processing were considered two independent events that occur sequentially in the cell. However, it has now been well established that transcription and pre-mRNA processing are two simultaneous processes that are precisely regulated inside the cell.
The chromatin structure, especially...
7.0K